Mitomycin medac clinical trials

HIVEC® HEAT - the drug mitomycin medac will be warmed to 43°C and administered through a catheter into the bladder via HIVEC® device for patients with nonmuscle-invasive bladder cancer that have previously had no response to BCG treatment

This study looks at a new way to treat bladder cancer that hasn't responded to usual treatment. It uses a warmed drug, mitomycin medac, delivered directly into the bladder to help people avoid bladder removal surgery.